Sutro Biopharma (STRO) Cash from Operations (2017 - 2025)
Sutro Biopharma (STRO) reported Cash from Operations of 26435000.0 for Q4 2025, up 63.15% on a YoY basis from 16202818.07 in Q4 2024, and up 30.78% sequentially from 38189000.0 in Q3 2025.
Sutro Biopharma (STRO) Cash from Operations (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Cash from Operations data on file, last reported at 26435000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations rose 63.15% year-over-year to 26435000.0; the trailing twelve-month figure through Dec 2025 stood at 177231000.0 (up 7.47% YoY), and the FY2025 full-year result was 177231000.0, up 7.47% from the prior year.
- Cash from Operations climbed to 26435000.0 in Q4 2025, from 38189000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 65854000.0 in Q3 2022 to a low of 71738000.0 in Q4 2024.
- A 5-year average of 27925850.0 and a median of 30812500.0 in 2021 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations jumped 369.83% in 2022 and plunged 879.13% in 2023, its largest moves.
- Tracing STRO's Cash from Operations over 5 years: stood at 21580000.0 in 2021, then decreased by 10.58% to 23864000.0 in 2022, then soared by 158.97% to 14072000.0 in 2023, then sank by 609.79% to 71738000.0 in 2024, then surged by 63.15% to 26435000.0 in 2025.
- Business Quant data shows STRO's Cash from Operations at 26435000.0 in Q4 2025, 38189000.0 in Q3 2025, and 44724000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -26.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.44 Mn |
| Dec 31, 2025 | -26.44 Mn |
| Sep 30, 2025 | -38.19 Mn |
| Sep 30, 2025 | -38.19 Mn |
| Jun 30, 2025 | -44.72 Mn |
| Jun 30, 2025 | -44.72 Mn |
| Mar 31, 2025 | -67.88 Mn |
| Mar 31, 2025 | -67.88 Mn |
| Dec 31, 2024 | -71.74 Mn |
| Dec 31, 2024 | -71.74 Mn |
| Sep 30, 2024 | -64.52 Mn |
| Sep 30, 2024 | -64.52 Mn |
| Jun 30, 2024 | 9.46 Mn |
| Jun 30, 2024 | 9.46 Mn |
| Mar 31, 2024 | -64.74 Mn |
| Mar 31, 2024 | -64.74 Mn |
| Dec 31, 2023 | 14.07 Mn |
| Dec 31, 2023 | 14.07 Mn |
| Sep 30, 2023 | -33.50 Mn |
| Sep 30, 2023 | -33.50 Mn |